|
|
|||
|
||||
OverviewDelineates the appropriate, sequential steps for the formulation of safe, effective, stable, and marketable liquid parenteral biopharmaceutical products--covering fundamentals and essential pathways for each phase as well as its purpose, function, and relation to other stages in the product development process. Written by experts currently involved in state-of-the-art advances in the pharmaceutical drug industry. Full Product DetailsAuthor: Cosimo Prantera , Burton I. Korelitz , Burton I. KorelitzPublisher: Taylor & Francis Inc Imprint: CRC Press Inc Volume: v. 85 Dimensions: Width: 15.20cm , Height: 1.80cm , Length: 22.90cm Weight: 0.660kg ISBN: 9780824799816ISBN 10: 082479981 Pages: 264 Publication Date: 25 July 1997 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsIntroduction to the Development of Biopharmaceutical Parenteral Dosage Forms, John A. Bontempo Fermentation Process Events Affecting Biopharmaceutical Quality, Anthony S. Lubiniecki Development of Recovery Processes for Recombinant Proteins and Peptides, Paula J. Shadle Preformulations Development of Parenteral Biopharmaceuticals, John A. Bontempo Formulations Development, John A. Bontempo The Analytical Techniques, Basant G. Sharma Membrane Filtration Technology, Forrest Badmington Considerations for Elastomeric Closures for Parenteral Biopharmaceutical Drugs, John A. BontempoReviews"""the real picture of how biopharmaceuticals develop for market readiness distinguishes itself. compact, pithy.[The author] put his own unique stamp on this volume to complete the real picture of how biopharmaceuticals develop for market readiness.""-Applied Genetics News, 1997" the real picture of how biopharmaceuticals develop for market readiness distinguishes itself. compact, pithy.[The author] put his own unique stamp on this volume to complete the real picture of how biopharmaceuticals develop for market readiness. -Applied Genetics News, 1997 Author InformationJohn A. Bontempo Tab Content 6Author Website:Countries AvailableAll regions |
||||